Utility of PharmacoGenomics for Reducing Adverse Drug Effects

Status unconfirmed

Conditions studied: Genetics of Drug Metabolism

In brief

UPGRADE aims to see whether data from Pharmacogenomic Testing (PGx) can help physicians manage patient medication regimens and assess if the testing has an effect on reducing adverse drug reactions, hospitalizations and emergency department visits. The way an individual processes a drug is in part determined by their genes, and there is known to be genetic variation between humans in the way drugs are metabolized. The study of the way genes affect a person's response to drugs is known as "Pharmacogenomics."

Key facts

Study ID
NCT02081872
Run by
Companion Dx Reference Lab, LLC
People needed
279000
Starts
2014-04-01
Expected to finish
2017-07-01
Last updated by the study team
2015-10-08

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.